» Articles » PMID: 29422797

Quality is the Key for Emerging Issues of Population-based Colonoscopy Screening

Overview
Journal Intest Res
Date 2018 Feb 10
PMID 29422797
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Colonoscopy is currently regarded as the gold standard and preferred method of screening for colorectal cancer (CRC). However, the benefit of colonoscopy screening may be blunted by low participation rates in population-based screening programs. Harmful effects of population-based colonoscopy screening may include complications induced by colonoscopy itself and by sedation, psychosocial distress, potential over-diagnosis, and socioeconomic burden. In addition, harmful effects of colonoscopy may increase with age and comorbidities. As the risk of adverse events in population-based colonoscopy screening may offset the benefit, the adverse events should be managed and monitored. To adopt population-based colonoscopy screening, consensus on the risks and benefits should be developed, focusing on potential harm, patient preference, socioeconomic considerations, and quality improvement of colonoscopy, as well as efficacy for CRC prevention. As suboptimal colonoscopy quality is a major pitfall of population-based screening, adequate training and regulation of screening colonoscopists should be the first step in minimizing variations in quality. Gastroenterologists should promote quality improvement, auditing, and training for colonoscopy in a population-based screening program.

Citing Articles

The adult large bowel: describing environment morphology for effective biomedical device development.

Norton J, Martin J, Winters C, Scaglioni B, Obstein K, Subramanian V Prog Biomed Eng (Bristol). 2024; 6(3).

PMID: 39655842 PMC: 11632178. DOI: 10.1088/2516-1091/ad6dbf.


Efficacy of colonoscopic re-examination across the entire colon: a randomized controlled trial.

Lee D, Ji J, Gweon T, Seo M, Choi H Surg Endosc. 2024; 38(11):6711-6717.

PMID: 39327294 DOI: 10.1007/s00464-024-11298-5.


Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program.

Brezina S, Leeb G, Baierl A, Graf E, Hackl M, Hofer P BMC Gastroenterol. 2024; 24(1):149.

PMID: 38689217 PMC: 11061958. DOI: 10.1186/s12876-024-03242-7.


Strategies to improve screening colonoscopy quality for the prevention of colorectal cancer.

Hye Song J, Ran Kim E Korean J Intern Med. 2024; 39(4):547-554.

PMID: 38247125 PMC: 11236814. DOI: 10.3904/kjim.2023.334.


Challenges and Suggestions in the Management of Stomach and Colorectal Cancer in Uzbekistan: The Third Report of the Uzbekistan-Korea Oncology Consortium.

Rim C, Lee W, Akhmedov O, Sabirov U, Ten Y, Ziyayev Y Int J Environ Res Public Health. 2023; 20(8).

PMID: 37107759 PMC: 10138433. DOI: 10.3390/ijerph20085477.


References
1.
Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O . Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348(9040):1467-71. DOI: 10.1016/S0140-6736(96)03430-7. View

2.
Bressler B, Paszat L, Vinden C, Li C, He J, Rabeneck L . Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology. 2004; 127(2):452-6. DOI: 10.1053/j.gastro.2004.05.032. View

3.
Inadomi J, Vijan S, Janz N, Fagerlin A, Thomas J, Lin Y . Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012; 172(7):575-82. PMC: 3360917. DOI: 10.1001/archinternmed.2012.332. View

4.
Cho Y, Kim D, Cha J, Jeen Y, Moon J, Kim J . Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea. Gut Liver. 2017; 11(6):821-827. PMC: 5669598. DOI: 10.5009/gnl17025. View

5.
Shin A, Choi K, Jun J, Noh D, Suh M, Jung K . Validity of fecal occult blood test in the national cancer screening program, Korea. PLoS One. 2013; 8(11):e79292. PMC: 3832630. DOI: 10.1371/journal.pone.0079292. View